Literature DB >> 8455229

The bladder mucus (glycosaminoglycan) layer in interstitial cystitis.

J C Nickel1, L Emerson, J Cornish.   

Abstract

The thin mucus or glycosaminoglycan layer of the bladder may be implicated in the pathogenesis of interstitial cystitis. We developed a specific anti-mucus, antisera stabilization technique to study the ultrastructural morphological appearance of the layer, and have used this technique to compare the surface morphology of 10 control and 10 interstitial cystitis patients. The electron micrographs demonstrate the ultrastructural characteristics of the pathological changes seen in interstitial cystitis but they did not show any significant difference in the morphological appearance of the mucus or glycosaminoglycan layer between the 2 groups.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8455229     DOI: 10.1016/s0022-5347(17)36191-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Treatment of refractory interstitial cystitis.

Authors:  A Morales; L Emerson; J C Nickel
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

Review 2.  Interstitial cystitis. Etiology, diagnosis, and treatment.

Authors:  J C Nickel
Journal:  Can Fam Physician       Date:  2000-12       Impact factor: 3.275

3.  Ultrastructural study of an antibody-stabilized bladder surface: a new perspective on the elusive glycosaminoglycan layer.

Authors:  J C Nickel; J Cornish
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

4.  Interstitial cystitis: characterization and management of an enigmatic urologic syndrome.

Authors:  J Curtis Nickel
Journal:  Rev Urol       Date:  2002

5.  The role of pentosan polysulfate in treatment approaches for interstitial cystitis.

Authors:  Joel Mh Teichman
Journal:  Rev Urol       Date:  2002

6.  Estrogen affects the glycosaminoglycan layer of the murine bladder.

Authors:  Mallika Anand; Caihong Wang; Jacob French; Megan Isaacson-Schmid; L Lewis Wall; Indira U Mysorekar
Journal:  Female Pelvic Med Reconstr Surg       Date:  2012 May-Jun       Impact factor: 2.091

7.  Long-term efficacy and tolerability of pentosan polysulphate sodium in the treatment of bladder pain syndrome.

Authors:  Ali A Al-Zahrani; Jerzy B Gajewski
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

8.  The significance of potassium chloride sensitivity test and urinary uronic acid level in the diagnosis of chronic pelvic pain syndrome.

Authors:  Bilal Firat Alp; Ilker Akyol; Cuneyt Adayener; Temucin Senkul; Mustafa Gultepe; Kadir Baykal; Cuneyt Iseri
Journal:  Int Urol Nephrol       Date:  2008-09-16       Impact factor: 2.370

Review 9.  Urinary and Serologic Markers forInterstitial Cystitis: An Update.

Authors:  David R Wilkinson; And Deborah R Erickson
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

10.  A high molecular weight hyaluronic acid biphasic dispersion as potential therapeutics for interstitial cystitis.

Authors:  Peadar R Rooney; Vijaya Krishna Kannala; Niranjan G Kotla; Ana Benito; Damien Dupin; Iraida Loinaz; Leo R Quinlan; Yury Rochev; Abhay Pandit
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2020-10-26       Impact factor: 3.368

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.